Free Trial

Lam Research Corporation $LRCX Shares Sold by Neville Rodie & Shaw Inc.

Lam Research logo with Computer and Technology background

Key Points

  • Neville Rodie & Shaw Inc. decreased its stake in Lam Research Corporation by 2.6%, selling 8,250 shares during the second quarter, leaving them with 314,442 shares valued at approximately $30.6 million.
  • Lam Research recently reported significant earnings, with $1.33 EPS surpassing estimates and a quarterly revenue increase of 33.6% year-over-year, reaching $5.17 billion.
  • The company announced a dividend increase to $0.26 per share, which represents an annualized yield of 0.9%, up from the previous dividend of $0.23.
  • Five stocks to consider instead of Lam Research.

Neville Rodie & Shaw Inc. lowered its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 2.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 314,442 shares of the semiconductor company's stock after selling 8,250 shares during the quarter. Lam Research comprises 2.3% of Neville Rodie & Shaw Inc.'s portfolio, making the stock its 9th largest position. Neville Rodie & Shaw Inc.'s holdings in Lam Research were worth $30,607,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Pinnacle Financial Partners Inc acquired a new stake in shares of Lam Research in the first quarter valued at about $201,000. Cookson Peirce & Co. Inc. acquired a new stake in shares of Lam Research in the first quarter valued at about $607,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Lam Research in the fourth quarter valued at about $6,296,000. China Universal Asset Management Co. Ltd. grew its stake in shares of Lam Research by 27.1% in the first quarter. China Universal Asset Management Co. Ltd. now owns 49,505 shares of the semiconductor company's stock valued at $3,607,000 after buying an additional 10,565 shares in the last quarter. Finally, First Citizens Bank & Trust Co. grew its stake in shares of Lam Research by 47.8% in the first quarter. First Citizens Bank & Trust Co. now owns 121,902 shares of the semiconductor company's stock valued at $8,862,000 after buying an additional 39,414 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company's stock.

Lam Research Trading Up 1.2%

NASDAQ:LRCX opened at $116.96 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. The business's 50 day moving average is $101.07 and its two-hundred day moving average is $86.69. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $117.50. The company has a market cap of $148.03 billion, a PE ratio of 28.12, a P/E/G ratio of 1.49 and a beta of 1.76.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. During the same quarter last year, the business posted $1.03 EPS. Lam Research's quarterly revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a yield of 0.9%. This is a boost from Lam Research's previous quarterly dividend of $0.23. Lam Research's dividend payout ratio (DPR) is 22.12%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on LRCX shares. Mizuho increased their target price on Lam Research from $120.00 to $130.00 and gave the company an "outperform" rating in a research note on Friday. KeyCorp increased their price target on Lam Research from $105.00 to $115.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. TD Cowen increased their price target on Lam Research from $100.00 to $125.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Wells Fargo & Company set a $98.00 price target on Lam Research and gave the company an "equal weight" rating in a report on Thursday, July 31st. Finally, Summit Insights downgraded Lam Research from a "buy" rating to a "hold" rating in a report on Thursday, July 31st. Twenty equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Lam Research presently has an average rating of "Moderate Buy" and a consensus target price of $107.96.

Get Our Latest Analysis on Lam Research

About Lam Research

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month
He Said Sell Oracle. Here’s What Happened Next.

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines